Abdalrhman Hamdan Alanizi

AFP α-fetoprotein DF decreased function DOX doxorubicin HCC hepatocellular carcinoma HWE Hardy–Weinberg equilibrium IF increased function IM intermediate metabolizer MAF minor allele frequency NF normal function NM normal metabolizer OR odds ratio OS overall survival PD pharmacodynamics PF poor function PFS progression-free survival PGx pharmacogenetic PharmGKB Pharmacogenomics Knowledge Base PK pharmacokinetics PM poor metabolizer QC quality control RM rapid metabolizer SNPs single...